NasdaqGM:EDAP

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. More Details


Snowflake Analysis

Reasonable growth potential with mediocre balance sheet.


Similar Companies

Share Price & News

How has EDAP TMS's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: EDAP's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

10.8%

EDAP

-0.7%

US Medical Equipment

-1.3%

US Market


1 Year Return

-1.0%

EDAP

24.8%

US Medical Equipment

18.5%

US Market

Return vs Industry: EDAP underperformed the US Medical Equipment industry which returned 24.8% over the past year.

Return vs Market: EDAP underperformed the US Market which returned 18.5% over the past year.


Shareholder returns

EDAPIndustryMarket
7 Day10.8%-0.7%-1.3%
30 Day16.9%4.8%5.3%
90 Day48.9%6.5%7.5%
1 Year-1.0%-1.0%25.9%24.8%21.3%18.5%
3 Year58.7%58.7%75.1%70.6%42.4%32.9%
5 Year7.0%7.0%150.5%131.0%84.2%63.5%

Price Volatility Vs. Market

How volatile is EDAP TMS's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is EDAP TMS undervalued compared to its fair value and its price relative to the market?

4.43x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: EDAP ($4.92) is trading above our estimate of fair value ($1.34)

Significantly Below Fair Value: EDAP is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: EDAP is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: EDAP is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EDAP's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EDAP is overvalued based on its PB Ratio (4.4x) compared to the US Medical Equipment industry average (4.1x).


Next Steps

Future Growth

How is EDAP TMS forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

60.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EDAP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).

Earnings vs Market: EDAP is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: EDAP's is expected to become profitable in the next 3 years.

Revenue vs Market: EDAP's revenue (19.6% per year) is forecast to grow faster than the US market (10.1% per year).

High Growth Revenue: EDAP's revenue (19.6% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EDAP's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has EDAP TMS performed over the past 5 years?

-3.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EDAP is currently unprofitable.

Growing Profit Margin: EDAP is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: EDAP is unprofitable, and losses have increased over the past 5 years at a rate of 3.6% per year.

Accelerating Growth: Unable to compare EDAP's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EDAP is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.5%).


Return on Equity

High ROE: EDAP has a negative Return on Equity (-6.13%), as it is currently unprofitable.


Next Steps

Financial Health

How is EDAP TMS's financial position?


Financial Position Analysis

Short Term Liabilities: EDAP's short term assets (€42.1M) exceed its short term liabilities (€17.5M).

Long Term Liabilities: EDAP's short term assets (€42.1M) exceed its long term liabilities (€8.2M).


Debt to Equity History and Analysis

Debt Level: EDAP's debt to equity ratio (18%) is considered satisfactory.

Reducing Debt: EDAP's debt to equity ratio has increased from 17.2% to 18% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if EDAP has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if EDAP has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is EDAP TMS current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate EDAP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EDAP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EDAP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EDAP's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EDAP's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.3yrs

Average management tenure


CEO

Marc Oczachowski (50 yo)

13.58yrs

Tenure

Mr. Marc Oczachowski has been Chief Executive Officer of EDAP TMS SA since March 31, 2007 and its Executive Director since July 1, 2017. Mr. Oczachowski serves as Executive Chairman of the Board at EDAP TM ...


Leadership Team

NamePositionTenureCompensationOwnership
Marc Oczachowski
Executive Chairman & CEO13.58yrsno datano data
François Dietsch
Chief Financial Officer5.25yrsno datano data
Blandine Confort
Investor Relations Officer and Secretaryno datano datano data
Frank Van Hyfte
Vice President of Global Sales & Marketing0.42yrno datano data

5.3yrs

Average Tenure

Experienced Management: EDAP's management team is seasoned and experienced (5.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Marc Oczachowski
Executive Chairman & CEO13.58yrsno datano data
Argil Wheelock
Independent Director11.33yrsno datano data
Philippe Chauveau
Independent Director23.5yrsno datano data
Pierre Beysson
Independent Director18.08yrsno datano data
Marie Meynadier
Director0.33yrno datano data
Robrecht L. Michiels
Independent Director11.25yrsno datano data

11.3yrs

Average Tenure

71yo

Average Age

Experienced Board: EDAP's board of directors are seasoned and experienced ( 11.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

EDAP TMS S.A.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: EDAP TMS S.A.
  • Ticker: EDAP
  • Exchange: NasdaqGM
  • Founded: 1979
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$143.377m
  • Shares outstanding: 29.14m
  • Website: https://www.edap-tms.com

Number of Employees


Location

  • EDAP TMS S.A.
  • Parc dActivites la Poudrette-Lamartine
  • 4/6, rue du DauphinE
  • Lyon
  • Rhône-Alpes
  • 69120
  • France

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EDAPNasdaqGM (Nasdaq Global Market)YesSPONSORED ADRUSUSDAug 1997
EDADB (Deutsche Boerse AG)YesSPONSORED ADRDEEURAug 1997

Biography

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/20 23:32
End of Day Share Price2020/10/20 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.